Get all premium features to the best stock analysis tool

Boone Capital added 398,482 shares of TYRA in the fourth quarter. The quarter-end position value rose by $10.48 million as a result of the new stake.

- Launched "dabogratinib 3x3" strategy to pursue 3 late-stage clinical studies in LG-UTUC, IR NMIBC and ACH, 3 potential blockbuster indications - - Interim Ph2 data readouts on track: SURF302 expected by end of 1H'26 and BEACH301 in 2H '26 - - Cash, cash equivalents and marketable securities of $256.0 million at Q4 2025; runway through at least 2027 - CARLSBAD, Calif., March 2, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today reported financial results for the fourth quarter and full-year ended December 31, 2025 and highlighted recent corporate progress.

CARLSBAD, Calif., Feb. 23, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that two abstracts have been accepted for presentation at the 2026 ASCO® Genitourinary (GU) Cancers Symposium (ASCO GU).

CARLSBAD, Calif., Feb. 19, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced participation at the following investor conferences: 36th Annual Oppenheimer Life Sciences Healthcare Conference Format: Virtual fireside chat and one-on-one investor meetingsPresentation Date/Time: Thursday, February 26, 2026 at 12:00pm ETLocation: Virtual 46th Annual TD Cowen Healthcare Conference Format: Hybrid presentation & fireside chat and one-on-one investor meetingsPresentation Date/Time: Wednesday, March 4th, 2026 at 11:50am ETLocation: Boston, MA Leerink Global Healthcare Conference Format: One-on-one investor meetingsDate: March 8-11, 2026Location: Miami, FL 2026 Jefferies Biotech on the Beach Summit Format: One-on-one investor meetingsDate: March 9-11, 2026Location: Miami, FL Barclays 28th Annual Global Healthcare Conference Format: One-on-one investor meetingsDate: March 10-12, 2026Location: Miami, FL A live webcast of the presentations can be accessed by visiting the "For Investors" page on the Tyra Biosciences  website and will be available for replay following the event.

Robert More reported the sale of 246,871 shares on Nov. 21 as part of a Rule 10b5-1 trading plan. The director still owns nearly 4 million shares, worth approximately $77.6 million.

CARLSBAD, Calif. , Dec. 1, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today the appointment of two key members of its leadership team: Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer.

CARLSBAD, Calif. , Nov. 12, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that members of company management will participate in the following investor events: Jefferies London Healthcare Conference Format: Hybrid presentation (slides & moderated Q&A) and one-on-one investor meetingsPresentation Date/Time: Wednesday, November 19, 2025, at 4:00 PM GMT Location: London, UK 37th Annual Piper Healthcare Conference Format: One-on-one investor meetingsDate: December 2-4, 2025 Location: New York, NY A live webcast of the Jefferies event can be accessed by visiting the "For Investors" page on the Tyra Biosciences  website  and will be available for replay following the event.